#Japan #Tokyo #Bone Health #Japanese Sigmax #Osteoporosis Society

Japanese Sigmax Enhances Bone Health Monitoring at the Upcoming Conference

Japanese Sigmax Co., Ltd., headquartered in Shinjuku, Tokyo, is set to exhibit at the 28th Japanese Osteoporosis Society Conference, taking place from September 11 to 13, 2026, at the Toki Messe Niigata Convention Center. The company aims to broaden the opportunities for assessing bone health and promoting awareness on osteoporosis.

A Commitment to Osteoporosis Management

For decades, Japanese Sigmax has specialized in the domain of physical activity support, primarily focusing on orthopedic medical devices and supplies that aid in the treatment and recovery of musculoskeletal disorders. Recently, the company has actively addressed the challenges faced by medical professionals, introducing products and services tailored to various treatment areas, thereby facilitating solutions for issues related to the musculoskeletal system.

Osteoporosis often progresses stealthily, leading to reduced physical function and an increased risk of fractures. Thus, early detection and appropriate medical intervention are crucial. Japanese Sigmax has been at the forefront of promoting bone health with various initiatives. They include the deployment of the LIAQUS Portable Ultrasound Bone Densitometer and conducting factual surveys on osteoporosis. Additionally, they participate in major conferences, such as the Japan Home Medical Alliance Conference and the Japan Primary Care Association Annual Meeting. They also organize webinars for general practitioners engaged in home healthcare, raising awareness about the importance of osteoporosis prevention and treatment.



The 28th Japanese Osteoporosis Society Conference is among the country's most prestigious academic gatherings for osteoporosis professionals. Through their participation, Japanese Sigmax seeks to underline the critical importance of monitoring bone health and share insights into initiatives that support early detection of osteoporosis. Their ultimate goal is to contribute to a society where everyone can enjoy an active lifestyle for an extended period.

Conference Details

• - Date: September 11 (Friday) to September 13 (Sunday), 2026
• - Venue: Toki Messe Niigata Convention Center
• - Official Website: Japanese Osteoporosis Society Conference
• - Booth Location: Toki Messe Niigata Convention Center, 1F Exhibition Hall A (Booth No. 18)

Exhibiting Products

During the conference, Japanese Sigmax will showcase an array of advanced medical devices aimed at osteoporosis prevention and treatment:
1. LIAQUS Portable Ultrasound Bone Densitometer: Designed for assessing bone health through ultrasound measurement of the calcaneus (heel bone).
- Model: FRS-100A
- Medical Device Certification: 305AHBZX00038000
- Classification: Management medical device

2. Pocket Echo MURICO CL5: A versatile ultrasound imaging device ideal for outpatient clinics and home healthcare settings.
- Medical Device Certification: 306AFBZX00100000
- Classification: Management medical device

3. Hybrid Splint Spine: A novel splint that combines the fixative strength of a plaster splint with the comfort of a support brace, suitable for spinal fractures.
- Certification: 13B2X00187000048

4. Max Belt FR: A lumbar support belt featuring a unique support mechanism and hard mesh material for enhanced body stability.

About Japanese Sigmax

Established on June 1, 1973, Japanese Sigmax is committed to advancing physical activity support in various fields, particularly orthopedic care. The company has built a robust portfolio of products designed to assist in injury prevention, diagnosis, treatment, and rehabilitation within the musculoskeletal domain. With a revenue of 16.22 billion yen for the fiscal year ending March 2026 and a workforce of 238 employees, they are recognized for their contributions to the healthcare sector.

For more information about their offerings, visit Japanese Sigmax Official Website.

Company Address: 1-24-1 Nishi-Shinjuku, Shinjuku Ward, Tokyo, Japan
Capital: 900 million yen
CEO: Yosuke Suzuki

With a mission to support greater health and quality of life through innovative product offerings, Japanese Sigmax exemplifies a commitment to healthcare excellence, ensuring that advancements in bone health contribute to the overall well-being of society.